Hepatitis B virus-induced hepatocellular carcinoma: The role of the virus x protein

Acta Virologica

Volumn 57, Issue 4, 2013, Pages 389-396

  Motavaf, M ^a   Safari, S ^a,b   Saffari Jourshari, M ^a,b   Alavian, S M ^a,c  

^a Middle East Liver Diseases Center (MELD Centers)   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; Epigenetic modifications; Hepatitis B virus; Hepatitis B x protein; Hepatocellular carcinoma; Nuclear excision repair

Indexed keywords

HEPATITIS B VIRUS X PROTEIN; TRANSACTIVATOR PROTEIN;

APOPTOSIS; ARTICLE; DNA MODIFICATION; DNA REPAIR; EPIGENETICS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NONHUMAN; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIRUS GENE; ANIMAL; CELL CYCLE; GENETICS; LIVER TUMOR; METABOLISM; PATHOPHYSIOLOGY; VIROLOGY;

HEPATITIS B VIRUS;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 84893414836     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: 10.4149/av_2013_04_389     Document Type: Article

References (52)

1. Abdel-Hafiz H (2011): Role of Hepatitis B virus X protein in DNA repair during hepatocellular carcinoma development. J. Carcinogen. Mutagen. S3, 37-39.
2. Alavian SM (2011): New globally faces of hepatitis B and C in the world. Gastroenterol. Hepatol. Bed Bench 4.
3. Andrisani OM, Barnabas S (1999): The transcriptional function of the hepatitis B virus X protein and its role in hepatocar-cinogenesis (Review). Int.l J. Onc. 15, 373-379.
4. Balsano C, Avantaggiati ML, Natoli G, De Marzio E, Will H, Per-ricaudet M, Levrero M (1991): Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the cmyc protooncogene at the transcrip-tional level. Biochem. Bioph. Res. Co. 176, 985-992. http://dx.doi.org/10.1016/0006-291X(91)90379-L
5. Benn J, Schneider RJ (1994): Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes aRas, Raf, MAP kinase signaling cascade. PNAS USA 91, 10350-10354. http://dx.doi.org/10.1073/pnas.91.22.10350
6. Benn J, Su, F, Doria M, Schneider RJ (1996): Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. J. Virol. 70, 4978-4985.
7. Bestor T, Laudano A, Mattaliano R, Ingram V (1988): Cloning and sequencing of acDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J. Mol. Biol. 203, 971-983. http://dx.doi.org/10.1016/0022-2836(88)90122-2
8. Bui-Nguyen TM, Pakala SB, Sirigiri DR, Martin E, Murad F, Kumar R (2010): Stimulation of inducible nitric oxide by hepa-titis B virus transactivator protein HBx requires MTA1 coregulator. J. Biol. Chem. 285, 6980-6986. http://dx.doi.org/10.1074/jbc.M109.065987
9. Chirillo P, Falco M, Puri PL, Artini M, Balsano C, Levrero M, Natoli G (1996): Hepatitis B virus pX activates NF-kappa B-dependent transcription through aRaf-independent pathway. J. Virol. 70, 641-646.
10. Ellis RE, Yuan J, Horvitz H (1991): Mechanisms and functions of cell death. Ann. Rev. Cell Biol. 7, 663-698. http://dx.doi.org/10.1146/annurev.cb.07.110191.003311
11. Feitelson MA (2006): Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocel-lular carcinoma. Cancer Lett. 239, 10-20. http://dx.doi.org/10.1016/j.canlet.2005.07.009
12. Gottlob K, Fulco M, Levrero M, Graessmann A (1998): The hepatitis B virus HBx protein inhibits caspase 3 activity. J. Biol. Chem. 273, 33347-33353. http://dx.doi.org/10.1074/jbc.273.50.33347
13. Holotnakova T, Tylkova L, Takacova M, Kopacek J, Petrik J, Pastore-kova S, Pastorek J (2010): Role of the HBx oncoprotein in carbonic anhydrase 9 induction. J. Med. Virol. 82, 32-40. http://dx.doi.org/10.1002/jmv.21671
14. Jung JK, Arora P, Pagano JS, Jang KL (2007): Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via aregulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway. Cancer Res. 67, 5771-5778. http://dx.doi.org/10.1158/0008-5472.CAN-07-0529
15. Jung JK, Park SH, Jang KL (2010): Hepatitis B virus X protein over-comes the growth-inhibitory potential of retinoic acid by downregulating retinoic acid receptor-β2 expression via DNA methylation. J. Gen. Virol. 91, 493-500. http://dx.doi.org/10.1099/vir.0.015149-0
16. Kim HJ, Kim SY, Kim J, Lee H, Choi M, Kim JK, Ahn, JK (2008): Hepatitis B virus X protein induces apoptosis by enhanc-ing translocation of Bax to mitochondria. IUBMB life 60, 473-480. http://dx.doi.org/10.1002/iub.68
17. Kim HR, Lee SH, Jung G (2010): The hepatitis B viral X protein activates NF-kappaB signaling pathway through the up-regulation of TBK1. FEBS Lett. 584, 525-530. http://dx.doi.org/10.1016/j.febslet.2009.11.091
18. Kim KH, Seong BL (2003): Pro-apoptotic function of HBV X pro-tein is mediated by interaction with c-FLIP and enhance-ment of death-inducing signal. EMBO J. 22, 2104-2116. http://dx.doi.org/10.1093/emboj/cdg210
19. Kim SY, Kim JK, Kim HJ, Ahn JK (2005): Hepatitis B vi-rus X protein sensitizes UV-induced apoptosis by transcriptional transactivation of Fas ligand gene expression. IUBMB Life 57, 651-658. http://dx.doi.org/10.1080/15216540500239697
20. Lara-Pezzi E, Gomez-Gaviro MV, Galvez BG, Mira E, Iniguez MA, Fresno M, Martinez AC, Arroyo AG, Lopez-Cabrera M (2002): The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metal-loproteinase-1 and cyclooxygenase-2 expression. J. Clin. Invest. 110, 1831-1838.
21. Lee JO, Kwun HJ, Jung JK, Choi KH, Min DS, Jang KL (2005): Hepa-titis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene 24, 6617-6625. http://dx.doi.org/10.1038/sj.onc.1208827
22. Lee SW, Lee YM, Bae SK, Murakami S, Yun,Y, Kim, KW (2000): Hu-man hepatitis B virus X protein is apossible mediator of hypoxia-induced angiogenesis in hepatocarcinogenesis. Biochem. Bioph. Res. Co. 268, 456-461. http://dx.doi.org/10.1006/bbrc.2000.2093
23. Lee YH, Yun Y (1998): HBx protein of hepatitis B virus activates Jak1-STAT signaling. J. Biol. Chem. 273, 25510-25515. http://dx.doi.org/10.1074/jbc.273.39.25510
24. Liu CJ, Kao JH (2007): Hepatitis B virus-related hepatocellular carcinoma: epidemiology and pathogenic role of viral factors. JCMA 70, 141-145.
25. Liu H, Shi W, Luan F, Xu S, Yang F, Sun W, Liu J, Ma C (2010a): Hepatitis B virus X protein upregulates transcriptional activation of human telomerase reverse transcriptase. Virus Genes 40, 174-182. http://dx.doi.org/10.1007/s11262-009-0441-3
26. Liu LP, Liang HF, Chen XP, Zhang WG, Yang SL, Xu T, Ren L (2010b): The role of NF-kappaB in Hepatitis b vi-rus X protein-mediated upregulation of VEGF and MMPs. Cancer Invest. 28, 443-451. http://dx.doi.org/10.3109/07357900903405959
27. Liu Q, Chen J, Liu L, Zhang J, Wang D, Ma L, He Y, Liu Y, Liu Z, Wu J (2011): The X protein of hepatitis B virus inhibits apop-tosis in hepatoma cells through enhancing the methionine adenosyltransferase 2A gene expression and reducing S-adenosylmethionine production. J. Biol. Chem. 286, 17168-17180. http://dx.doi.org/10.1074/jbc.M110.167783
28. Lu SN, Su WW, Yang SS, Chang TT, Cheng KS, Wu JC, Lin HH, Wu SS, Lee CM, Changchien CS, Chen CJ, Sheu JC, Chen DS, Chen CH (2006): Secular trends and geographic vari-ations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan. Int. J. Cancer 119, 1946-1952. http://dx.doi.org/10.1002/ijc.22045
29. Mahboobi N, Agha-Hosseini F, Safari S, Lavanchy D, Alavian SM (2010): Hepatitis B virus infection in dentistry: aforgot-ten topic. J. Viral Hepatitis 17, 307-316. http://dx.doi.org/10.1111/j.1365-2893.2010.01284.x
30. Motavaf M, Alavian SM (2012): RNA interference: apromising approach for the treatment of viral hepatitis. Hepatitis Monthly 12, 7-8.
31. Motavaf M, Safari S, Alavian SM (2012): Therapeutic potential of RNA interference: anew molecular approach to antiviral treatment for hepatitis C. J. Viral. Hepatitis 19, 757-765. http://dx.doi.org/10.1111/jvh.12006
32. Murata M, Matsuzaki K, Yoshida K, Sekimoto G, Tahashi Y, Mori S, Uemura,Y, Sakaida N, Fujisawa J, Seki T, Kobayashi K, Yokote K, Koike K, Okazaki K (2009): Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B. Hepatology 49, 1203-1217. http://dx.doi.org/10.1002/hep.22765
33. Okano M, Xie S, Li E (1998): Cloning and characterization of a family of novel mammalian DNA (cytosine-5) meth-yltransferases. Nat. Genet. 19, 219-220. http://dx.doi.org/10.1038/890
34. Ou DP, Tao YM, Tang FQ, Yang LY (2007): The hepatitis B virus X protein promotes hepatocellular carcinoma metastasis by upregulation of matrix metalloproteinases. Int. J. Cancer 120, 1208-1214. http://dx.doi.org/10.1002/ijc.22452
35. Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH, Surzycki SJ, Lee YI (2007): Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology 132, 1476-1494. http://dx.doi.org/10.1053/j.gastro.2007.01.034
36. Rahmani Z, Huh KW, Lasher R, Siddiqui A (2000): Hepatitis B virus X protein colocalizes to mitochondria with ahuman voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J. Virol. 74, 2840-2846. http://dx.doi.org/10.1128/JVI.74.6.2840-2846.2000
37. Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S (2001): Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation sta-tus on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Hepatology 33, 561-568. http://dx.doi.org/10.1053/jhep.2001.22507
38. Samuels-Lev Y, O'Connor DJ, Bergamaschi,D, Trigiante G, Hsieh JK, Zhong S, Campargue I, Naumovski L, Crook T, Lu, X (2001): ASPP proteins specifically stimulate the apop-totic function of p53. Mol. Cell 8, 781-794. http://dx.doi.org/10.1016/S1097-2765(01)00367-7
39. Shirakata Y, Koike K (2003): Hepatitis B virus X protein induces cell death by causing loss of mitochondrial membrane potential. J. Biol. Chem. 278, 22071-22078. http://dx.doi.org/10.1074/jbc.M301606200
40. Su F, Schneider RJ (1997): Hepatitis B virus HBx protein sensi-tizes cells to apoptotic killing by tumor necrosis factor α. PNAS 94, 8744-8749. http://dx.doi.org/10.1073/pnas.94.16.8744
41. Su IJ, Wang HC, Wu HC, Huang, WY (2008): Ground glass hepatocytes contain pre-Smutants and represent pre-neoplastic lesions in chronic hepatitis B virus infection. J. Gastroenterol. Hepatol. 23, 1169-1174. http://dx.doi.org/10.1111/j.1440-1746.2008.05348.x
42. Takada S, Shirakata Y, Kaneniwa N, Koike K (1999): Association of hepatitis B virus X protein with mitochondria causes mitochondrial aggregation at the nuclear periphery, lead-ing to cell death. Oncogene 18, 6965-6973. http://dx.doi.org/10.1038/sj.onc.1203188
43. Twu JS, Lai MY, Chen DS, Robinson WS (1993): Activation of protooncogene c-jun by the X protein of hepatitis B virus. Virology 192, 346-350. http://dx.doi.org/10.1006/viro.1993.1041
44. Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Stürz-becher HW, Hoeijmakers JHJ, Harris CC (1995): Abroga-tion of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res. 55, 6012-6016.
45. Wang Y, Lu Y, Toh ST, Sung WK, Tan P, Chow P, Chung AY, Jooi LL, Lee CG (2010): Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. J. Hepatology 53, 57-66. http://dx.doi.org/10.1016/j.jhep.2009.12.043
46. Xu X, Fan Z, Kang L, Han J, Jiang C, Zheng X, Zhu Z, Jiao H, Lin J, Jiang K, Ding L, Zhang H, Cheng L, Fu H, Song Y, Jiang Y, Liu J, Wang R, Du N, Ye Q (2013): Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. J. Clin. Invest. 123, 630-645.
47. Yang B, Guo M, Herman JG, Clark DP (2003): Aberrant promoter methylation profiles of tumor suppressor genes in hepa-tocellular carcinoma. Am. J. Pathol. 163, 1101. http://dx.doi.org/10.1016/S0002-9440(10)63469-4
48. Zhang SM, Sun DC, Lou S, Bo XC, Lu Z, Qian XH, Wang SQ (2005a): HBx protein of hepatitis B virus (HBV) can form complex with mitochondrial HSP60 and HSP70. Arch. Virol. 150, 1579-1590. http://dx.doi.org/10.1007/s00705-005-0521-1
49. Zhang X, Dong N, Yin L, Cai N, Ma H, You J, Zhang H, Wang H, He R, Ye L (2005b): Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues. J. Med. Virol. 77, 374-381. http://dx.doi.org/10.1002/jmv.20466
50. Zhao J, Wu G, Bu F, Lu B, Liang A, Cao L, Tong X, Lu X, Wu M, Guo Y (2010): Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region-con-taining protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocel-lular carcinoma. Hepatology 51, 142-153. http://dx.doi.org/10.1002/hep.23247
51. Zhu YZ, Zhu R, Shi LG, Mao Y, Zheng GJ, Chen Q, Zhu HG (2010): Hepatitis B virus X protein promotes hypermeth-ylation of p16INK4A promoter through upregulation of DNA methyltransferases in hepatocarcinogenesis. Exp. Mol. Pathol. 89, 268-275. http://dx.doi.org/10.1016/j.yexmp.2010.06.013
52. Zou SQ, Qu ZL, Li ZF, Wang X (2004): Hepatitis B virus X gene induces human telomerase reverse transcriptase mRNA expression in cultured normal human cholangiocytes. World J. Gastroenterol. 10, 2259-2262.